ROR1 and cancer: The restricted expression of ROR1 in normal adult tissues compared to its frequent overexpression in cancer, specifically in CSCs, makes it an attractive target for therapies aimed at eliminating both CSCs and differentiated cancer cells while minimizing off-target toxicity.